Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Vaccin Immunother ; 19(2): 2222649, 2023 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-37381762

RESUMO

During the pandemic period, many regulations were made to reduce the spread of the epidemic throughout the country and restrictions were applied. We aimed to interpret the effects of vaccination status, total number of vaccination doses and preferred vaccine type on the prognostic process of the patients we treated inpatients with the diagnosis of Covid-19 in our pandemic service. The present descriptive cross-sectional study was conducted in Ordu, Turkey. One hundred and fifty-two people participated. 80.9% (n = 123) of whom were vaccinated against SARS-Cov-2, and 19.1% (n = 29) were unvaccinated. When the treatment processes of the participants were analyzed in general, it was observed that the clinical condition of the individuals who received at least one dose of BNT162b2 vaccine did not worsen (χ2 = 40.080; p = .011). It was determined that BNT162b2 vaccine was not among the vaccine preferences of the cases who needed to be transferred to the intensive care unit in this process and whose clinical processes resulted in death during follow-up in intensive care or service after intensive care referral (χ2 = 64.417; p = .024). According to these results, our study proves once again the protective role of vaccines against epidemic diseases and their progression.


Assuntos
COVID-19 , Vacinas , Humanos , Vacina BNT162 , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Estudos Transversais , Estudos Prospectivos , SARS-CoV-2 , Vacinação , Pandemias
2.
Med Hypotheses ; 143: 110119, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32721811

RESUMO

Irritable bowel syndrome (IBS) is a common disorder worldwide, but the diagnosis is often overlooked. This study aimed to evaluate the sociodemographic characteristics of IBS patients and the relationship between IBS and fibromyalgia. 202 patients with gastrointestinal system complaints who were admitted to Sisli Hamidiye Etfal Trainnig and Research Hospital, Family Medicine Clinic were included in the study. P < 0.05 was considered statistically significant. Fibromyalgia was associated with IBS in 26.7% of the participants. There was a positive correlation between the incidence of fibromyalgia and use of medication due to IBS, change in stool frequency, generalized pain, frequent illness, headache, excessive stress cancer anxiety , workforce loss due to IBS symptoms and fibromyalgia (p < 0.05). The presence of generalized pain, among IBS symptoms, caused the most robust increase in the likelihood of fibromyalgia (80%). The symptoms which were increasing the possibility of fibromyalgia were mostly generalized pain, high WHOQOL total score, family history of cancer, and loss of workforce at admission. IBS is a condition that affects the daily life quality of individuals and is often a condition that can be confused or associated with other diseases. Primary care physicians should approach patients holistically, especially in patients with generalized pain, family history of cancer, loss of workforce at admission, and more careful about fibromyalgia in patients with high WHOQOL total score. This awareness will increase the chances of early diagnosis and treatment of patients and will provide less cost but more effective treatment.


Assuntos
Fibromialgia , Síndrome do Intestino Irritável , Detecção Precoce de Câncer , Fibromialgia/complicações , Fibromialgia/diagnóstico , Humanos , Síndrome do Intestino Irritável/complicações , Síndrome do Intestino Irritável/diagnóstico , Dor , Qualidade de Vida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...